-
Product Insights
Net Present Value Model: Myozyme/Lumizyme
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Myozyme/Lumizyme Drug Details Alglucosidase alfa (Myozyme)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Vaccine for Crohn’s Disease and Mycobacterium avium Infections
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry Vaccine for Crohn's Disease and Mycobacterium avium Infections Drug Details Vaccine is under development...
-
Product Insights
Glycogen Storage Disorders (GSD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Glycogen Storage Disorders (GSD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Glycogen Storage Disorders (GSD) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Glycogen Storage Disorders (GSD), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history...
-
Product Insights
COVID 19 point of care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021
COVID-19 point of care (POC) tests are used to detect the presence or activity of COVID-19 antigen. This segment includes rapid tests and point of care tests for COVID-19. The COVID-19 POC tests pipeline products report provides comprehensive information about the COVID 19 point of care tests pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The report also provides information on the pipeline products...
-
Product Insights
COVID 19 Nucleic Acid Amplification Tests (NAATs) – Medical Devices Pipeline Assessment, 2020
COVID 19 NAAT tests are highly sensitive tests and can easily detect the low density infections. The types of NAAT tests are Polymerase chain reaction (PCR) – including nested (n), quantitative (q) or real-time reverse transcription (RT) PCR), quantitative nucleic acid sequence-based amplification (QT-NASBA) and loop mediated isothermal amplification (LAMP). GlobalData's Medical Devices sector report, “COVID 19 Nucleic Acid Amplification Tests (NAATs) - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the COVID 19 Nucleic Acid Amplification Tests (NAATs)...
-
Product Insights
Glycogen Storage Disorders (GSD) Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Glycogen Storage Disorders (GSD) Global Clinical Trials Review, H2, 2017" provides an overview of Glycogen Storage Disorders (GSD) clinical trials scenario. This report provides top line data relating to the clinical trials on Glycogen Storage Disorders (GSD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Sector Analysis
Power Market in CARICOM and Associated Countries – Installed Capacity, Capacity Mix, Renewable Roadmap, Electricity Tariffs and Future Outlook to 2030
“Power Market in CARICOM and Associated Countries – Installed Capacity, Capacity Mix, Renewable Roadmap, Electricity Tariffs and Future Outlook to 2030” is the latest market analysis report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the power market in the Caribbean Community (CARICOM) and associated countries. The report provides a clear overview of and detailed insight into the power market in CARICOM and associated countries. The report provides power market scenario and outlook for thirty...
-
Government & Regulation
Papua New Guinea’s Mining Fiscal Regime H1 2016
GlobalData's fiscal regime report covers Papua New Guinea which has a variety of natural resources such as gold, copper, silver and natural gas. The Mineral Resources Authority (MRA) is the authority responsible for governing the mining industry in the country. The Mining Act 1992 is the apex law for the mining industry.
-
Sector Analysis
Belize Power Market Outlook to 2030, Update 2019-Market Trends, Regulations, Electricity Tariff and Key Company Profiles
This report elaborates Belize's power market structure and provides historical and forecast numbers for capacity, generation, and consumption up to 2030. Detailed analysis of the country's power market regulatory structure, key company profiles, and electricity tariffs are provided. The report also gives a snapshot of the power sector in the country on broad parameters of macroeconomics, supply security, generation infrastructure, transmission infrastructure, degree of competition, regulatory scenario, and future potential.